GlassScriptPhysician profile
Chaman L Sohal
NPI 1699758920
$10,338.25
in general payments reported to CMS, 2019-2025
38 companies · $1,231 in 2025
The $1,231 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,963 · 2020: $895 · 2021: $831 · 2022: $1,309 · 2023: $1,356 · 2024: $2,753 · 2025: $1,231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,169 · Travel and Lodging: $1,170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,169.40 |
| Travel and Lodging | $1,169.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,542.66 | 2023-2024 | Pascal, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Endologix LLC | $1,499.33 | 2019-2025 | Alto Abdominal Stent Graft System, Afx2 Bifurcated Endograft System, Endocross Device |
| Medtronic Vascular, INC. | $680.39 | 2019-2020 | |
| Abbott Laboratories | $677.27 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $632.04 | 2019-2025 | Emblem Mri S-Icd, Lux-Dx Insertable Cardiac Monitor, Peripheral Rotalink Plus |
| E.R. Squibb & Sons, L.L.C. | $600.35 | 2019-2025 | Camzyos, Eliquis |
| Medtronic, INC. | $520.10 | 2021-2024 | Cobalt Dr Mri Surescan, Micra |
| Merck Sharp & Dohme LLC | $453.91 | 2021-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $450.26 | 2019-2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $301.65 | 2019-2024 | Lifevest |
| Kestra Medical Technology Services, INC. | $290.70 | 2023-2025 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $275.36 | 2019-2024 | Farxiga, Wainua |
| Impulse Dynamics (USA) INC. | $207.90 | 2023 | Optimizer |
| Medline Industries LP | $198.63 | 2019 | |
| Astellas Pharma US INC | $189.98 | 2019 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chaman Sohal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.